APGE
Price
$37.87
Change
+$0.74 (+1.99%)
Updated
Sep 5 closing price
Capitalization
2.26B
73 days until earnings call
DYN
Price
$14.22
Change
+$0.98 (+7.40%)
Updated
Sep 5 closing price
Capitalization
2.02B
54 days until earnings call
Interact to see
Advertisement

APGE vs DYN

Header iconAPGE vs DYN Comparison
Open Charts APGE vs DYNBanner chart's image
Apogee Therapeutics
Price$37.87
Change+$0.74 (+1.99%)
Volume$498.29K
Capitalization2.26B
Dyne Therapeutics
Price$14.22
Change+$0.98 (+7.40%)
Volume$2.42M
Capitalization2.02B
APGE vs DYN Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. DYN commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and DYN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (APGE: $37.87 vs. DYN: $14.22)
Brand notoriety: APGE and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 62% vs. DYN: 81%
Market capitalization -- APGE: $2.26B vs. DYN: $2.02B
APGE [@Biotechnology] is valued at $2.26B. DYN’s [@Biotechnology] market capitalization is $2.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, both APGE and DYN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while DYN’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 3 bearish.
  • DYN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both APGE and DYN are a good buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а +4.12% price change this week, while DYN (@Biotechnology) price change was +5.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

DYN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.26B) has a higher market cap than DYN($2.02B). APGE YTD gains are higher at: -16.402 vs. DYN (-39.643). APGE has higher annual earnings (EBITDA): -270.1M vs. DYN (-437.37M). DYN has more cash in the bank: 684M vs. APGE (505M). APGE has less debt than DYN: APGE (10.8M) vs DYN (121M). APGE (0) and DYN (0) have equivalent revenues.
APGEDYNAPGE / DYN
Capitalization2.26B2.02B112%
EBITDA-270.1M-437.37M62%
Gain YTD-16.402-39.64341%
P/E RatioN/AN/A-
Revenue00-
Total Cash505M684M74%
Total Debt10.8M121M9%
TECHNICAL ANALYSIS
Technical Analysis
APGEDYN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PVFAX58.110.41
+0.71%
Paradigm Value
DODWX16.200.07
+0.43%
Dodge & Cox Global Stock I
OSCYX23.88N/A
N/A
Invesco Main Street Small Cap Y
NFALX35.32-0.17
-0.48%
Neuberger Berman Focus I
VPRDX13.72-0.07
-0.51%
VY® Morgan Stanley Global Franchise R6

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+1.99%
SYRE - APGE
54%
Loosely correlated
+0.06%
CRNX - APGE
50%
Loosely correlated
+3.97%
IDYA - APGE
48%
Loosely correlated
+5.15%
DYN - APGE
48%
Loosely correlated
+7.40%
CGON - APGE
47%
Loosely correlated
+6.88%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+7.40%
RNA - DYN
58%
Loosely correlated
+3.90%
CRNX - DYN
54%
Loosely correlated
+3.97%
SYRE - DYN
52%
Loosely correlated
+0.06%
XNCR - DYN
51%
Loosely correlated
+2.15%
IDYA - DYN
50%
Loosely correlated
+5.15%
More